Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.99 USD | -1.96% | -3.62% | -11.25% |
Feb. 26 | Healthstream Insider Sold Shares Worth $408,750, According to a Recent SEC Filing | MT |
Feb. 26 | Tranche Update on HealthStream, Inc.'s Equity Buyback Plan announced on September 13, 2023. | CI |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The opinion of analysts covering the stock has improved over the past four months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 46.73 times its estimated earnings per share for the ongoing year.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-11.25% | 741M | C+ | ||
+21.29% | 208B | B+ | ||
+3.52% | 151B | B | ||
+12.78% | 56.98B | D+ | ||
+11.89% | 32.1B | B+ | ||
-0.15% | 28.66B | C+ | ||
+91.28% | 20.95B | D+ | ||
+17.81% | 18.89B | B- | ||
+8.76% | 14.28B | B | ||
-2.35% | 14.23B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- HSTM Stock
- Ratings HealthStream, Inc.